A Test of Survival
Description:
A simple lab test that could customize chemotherapy to the patient and save lives. Surely such a breakthrough would be hustled into widespread use? Not in A Test of Survival, and not in the real-life story that inspired it. Money is certainly at stake, as is status, power, loyalty to petrified ideas, and the fate of half a million people dying of cancer every year.Dr. Gus Ephraim toils for decades at the fringes of cancer research, stubbornly awaiting validation of his tumor test. He risks his marriage and more when he sets up a new lab in the Midwest, too close to wife number one and to Dr. Lyman Deering, renowned leader in the cancer establishment. As damage to his reputation, his livelihood, and his family piles up Gus stops playing by the rules. Reluctantly, and prodded by an unlikely band of allies, he takes on the powers-that-be and their cash-register vision of cancer treatment in America.Visit www.marniesfiction.com Ten percent of the royalties from this book will be donated to Gilda's Club, a network of meeting places for the support of cancer patients, their families and friends.
Best prices to buy, sell, or rent ISBN 9780595363117
Frequently Asked Questions about A Test of Survival
You can buy the A Test of Survival book at one of 20+ online bookstores with BookScouter, the website that helps find the best deal across the web. Currently, the best offer comes from and is $ for the .
The price for the book starts from $12.85 on Amazon and is available from 12 sellers at the moment.
If you’re interested in selling back the A Test of Survival book, you can always look up BookScouter for the best deal. BookScouter checks 30+ buyback vendors with a single search and gives you actual information on buyback pricing instantly.
As for the A Test of Survival book, the best buyback offer comes from and is $ for the book in good condition.
The A Test of Survival book is in very low demand now as the rank for the book is 8,144,979 at the moment. A rank of 1,000,000 means the last copy sold approximately a month ago.
Not enough insights yet.